Inside this Issue ISSUE 1 | VOLUME 2
» »
»
»
What effects do common medications used to treat rheumatoid arthritis (RA) have on the cardiovascular system? Why are the use of glucocorticoids and NSAIDs dangerous in the treatment of RA patients at risk for developing cardiovascular disease (CVD)? What models are available to improve multidisciplinary care and reduce the risk of the development of CVD in patients with RA? What is self-efficacy, and why it is important to assess in patients with RA?
EDUCAT ION A L P L A N N I N G CO M M ITTE E :
Sheree C. Carter, PhD, RN Assistant Professor The University of Alabama Capstone College of Nursing Tuscaloosa, Alabama
Iris Zink, MSN, NP Nurse Practitioner Beals Institute Lansing, Michigan
Elizabeth Kirchner, CNP Nurse Practitioner Cleveland Clinic Cleveland, Ohio
Jacqueline Fritz, RN, MSN, CNS, RNBC Critical Care and Rheumatology Specialist Medical Advancement Center Cypress, California
RNSnurse.org